Blinatumomab (Blincyto) Kit from Japan
Blinatumomab (Blincyto) is a bispecific T-cell engager monoclonal antibody used for treating acute lymphoblastic leukemia (ALL). It is presented as a kit with measured doses for retail sale, qualifying under tariff item 3002.15.00 as an immunological product. This product directly regulates immunological processes by engaging T-cells.
Duty Rate — Japan → Canada
0%
Import Tips
• Ensure the kit components are clearly labelled as a set for retail sale
• Provide clinical documentation showing the immunological mechanism for customs
• Check if a Special Access Programme request is needed for importation